Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Mixtard

Mixtard 30 40 international units/ml suspension for injection in vial. Mixtard 30 100 international units/ml suspension for injection in vial. Mixtard 30 Penfill 100 international units/ml suspension for injection in cartridge. Mixtard 30 InnoLet 100 international units/ml suspension for injection in pre-filled pen. Mixtard 30 FlexPen 100 international units/ml suspension for injection in pre-filled pen. · Abschnitt 4.8 · PDF-Seite 6–7

HOS-111163 · Präparat HOS-093463

6 At the beginning of the insulin treatment, refraction anomalies, oedema and injection site reactions (pain, redness, hives, inflammation, bruising, swelling and itching at the injection site) may occur. These reactions are usually of a transitory nature. Fast improvement in blood glucose control may be associated with acute painful neuropathy, which is usually reversible. Intensification of insulin therapy with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy, while long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.